![Lorence Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lorence Kim
Directeur/Membre du Conseil chez
REVOLUTION MEDICINES, INC.
Fortune : 15 M $ au 31/07/2026
Profil
Dr. Lorence H.
Kim is a Co-Founder & Managing Partner at Ascenta Capital Management LLC, an Independent Director at Revolution Medicines, Inc. and a Chief Financial Officer at ModernaTX, Inc. He is on the Board of Directors at ADARx Pharmaceuticals, Inc., Revolution Medicines, Inc., Abata Therapeutics, Inc., Flare Therapeutics, Inc., American Red Cross, Inc. and Prep for Prep.
Dr. Kim was previously employed as an Independent Director by Cencora, Inc., an Independent Director by Cowen, Inc., a Venture Partner by Third Rock Ventures LLC, an Independent Director by Seres Therapeutics, Inc., a Chief Financial Officer by Moderna, Inc., and a Managing Director by Goldman Sachs & Co. He also served on the board at Odyssey Therapeutics, Inc. He received his undergraduate degree from Harvard University, an MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from the University of Pennsylvania Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/06/2026 | 74 281 ( 0,03 % ) | 14 M $ | 31/07/2026 | |
| 05/03/2026 | 4 081 ( 0 % ) | 1 M $ | 31/07/2026 |
Postes actifs de Lorence Kim
| Sociétés | Poste | Début |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Directeur/Membre du Conseil | 12/07/2022 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Directeur Financier/CFO | - |
American Red Cross, Inc.
 American Red Cross, Inc. Services to the Health IndustryHealth Services Provides individual and family social services | Directeur/Membre du Conseil | - |
Ascenta Capital
 Ascenta Capital Investment ManagersFinance Ascenta Capital is an active manager. | Fondateur | 01/01/2023 |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Directeur/Membre du Conseil | 20/01/2023 |
Prep for Prep
 Prep for Prep Miscellaneous Commercial ServicesCommercial Services Engages in leadership development program activities | Directeur/Membre du Conseil | - |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Directeur/Membre du Conseil | - |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Directeur/Membre du Conseil | 01/06/2021 |
Anciens postes connus de Lorence Kim
| Sociétés | Poste | Fin |
|---|---|---|
| CENCORA, INC. | Directeur/Membre du Conseil | 13/08/2026 |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Lorence Kim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Cencora, Inc.
 Cencora, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Prep for Prep
Prep for Prep Miscellaneous Commercial ServicesCommercial Services Engages in leadership development program activities | Commercial Services |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
American Red Cross, Inc.
American Red Cross, Inc. Services to the Health IndustryHealth Services Provides individual and family social services | Health Services |
Cowen, Inc.
 Cowen, Inc. Investment Banks/BrokersFinance Provides corporate & investment banking and financial services | Finance |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Health Technology |
Ascenta Capital
Ascenta Capital Investment ManagersFinance Ascenta Capital is an active manager. | Finance |
